Related Experiment Video
Updated: Dec 6, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Which is the best prosthesis in an isolated or combined tricuspid valve replacement?
Peng Liu1, Dong-Sheng Xia1, Wei-Hua Qiao2
1Department of Cardiovascular Surgery, Fuwai Central China Cardiovascular Hospital, Henan Province People's Hospital, Henan Cardiovascular Hospital and Zhengzhou University, Zhengzhou, Henan, China.
Insights
For isolated tricuspid valve replacement, biological prostheses show better long-term outcomes than mechanical ones, particularly for patients without Ebstein's anomaly. This suggests individualized patient care for tricuspid valve prostheses.
Area of Science:
- Cardiac Surgery
- Cardiovascular Research
- Prosthetic Valve Development
Background:
- The optimal choice of tricuspid valve prostheses remains a subject of ongoing debate in cardiac surgery.
- Comparing mechanical and biological prostheses is crucial for long-term patient management.
Purpose of the Study:
- To compare the long-term results of mechanical versus biological prostheses in tricuspid valve replacement.
- To evaluate outcomes in both isolated and combined tricuspid valve replacement surgeries.
Main Methods:
- A retrospective study of 338 patients undergoing tricuspid valve replacement between 1999 and 2018.
- Patients were categorized into isolated or combined surgery groups and received either mechanical or bioprosthetic valves.
- Comparison of operative results, long-term survival, and tricuspid valve-related events.
Main Results:
- Early mortality was higher in the combined group but similar between valve types. In isolated replacement, biological valves had a higher event-free rate (P=0.042), especially without Ebstein's anomaly (P=0.039).
- No significant difference in event rates was found in the combined group (P=0.98).
- Survival rates were comparable between mechanical and biological valves in both isolated (P=0.54) and combined (P=0.81) groups. Mechanical valves in isolated procedures showed higher risks of thrombosis and bleeding.
Conclusions:
- Tricuspid valve prosthesis selection should be individualized.
- Biological prostheses may be optimal for isolated tricuspid valve replacement, particularly in patients without Ebstein's anomaly.
- Further research into patient-specific factors influencing prosthesis choice is warranted.
Objectives:
The debate concerning the optimal choice of tricuspid position continues. We compared the long-term results of mechanical and biological prostheses in patients who underwent isolated or combined tricuspid valve replacement, at 2 major cardiac surgical centres in central China.
Methods:
From January 1999 to December 2018, 338 patients underwent tricuspid valve replacement. Patients were divided into an isolated group or a combined group according to whether their surgery was combined with a left heart valve surgery. Mechanical tricuspid valve replacement was performed in 142 patients (isolated group: 41 vs combined group: 101), and 196 patients underwent bioprosthetic tricuspid valve replacement (isolated group: 145 vs combined group: 51). Operative results, long-term survival and tricuspid valve-related events were compared.
Results:
Early mortality in the combined group was higher (n = 6, 4%) than that in the isolated group (n = 3, 2%), but no significant difference was observed between the mechanical and biological subgroups. In the isolated group, there was a higher event-free rate in the biological subgroup than in the mechanical subgroup (P = 0.042) and a similar result was also observed for patients without Ebstein's anomaly (P = 0.039). In the combined group, no significant difference was observed (P = 0.98). Survival rates were similar between the mechanical and biological subgroups in both the isolated (P = 0.54) and combined (P = 0.81) groups. Mechanical valves in isolated tricuspid valve replacement were more prone to valve thrombosis and bleeding.
Conclusions:
Every decision regarding tricuspid valve prostheses should be individualized, but biological prostheses may be an optimal choice for patients, especially for patients without Ebstein's anomaly, in isolated tricuspid valve replacement.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse I: Introduction

